13F Holdings
中文EN

FCHS First Choice Healthcare Solutions, Inc.

Services-Medical Laboratories · OTC · SEC CIK 1416876 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-552.3%
TTM EPS YoY-518.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets657.7%
Debt / equity—
Current ratio0.01x
Interest coverage-0.14x

Cash quality & payout

Operating cash flow / net income0.12x
Accruals ratio-645.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20172017-12-31
Income statement
Revenue—————
Gross profit$7,350—$29,985$1.07M—
SG&A expense$1.88M$906,815$2.19M$3.62M$5.59M
Operating income-$2.67M-$1.29M-$2.41M-$7.02M-$4.41M
Interest expense$4.71M$3.35M$5.92M$3.71M—
Pretax income-$6.96M-$3.74M-$8.17M-$9.94M-$4.39M
Income tax—$111,950———
Net income-$6.96M-$3.85M-$8.17M-$9.94M$3.89M
EBITDA-$2.65M-$1.25M-$2.37M-$6.93M-$3.47M
EPS (basic)—-0.12-0.25-0.30-0.15
EPS (diluted)-0.21-0.12-0.25-0.30-0.15
Weighted avg. shares (diluted)32.96M32.96M32.96M32.96M26.66M
Banking
Deposits————$2,269
Balance sheet
Cash & equivalents$5,896$19,915$12,607$7,219$2.02M
Receivables$717$72,270$92,444$304,873$8.70M
Current assets$6,613$92,185$107,634$1.33M$12.55M
PP&E, net$146,961$222,816$262,243$470,703$2.30M
Goodwill————$899,465
Total assets$4.05M$4.51M$3.12M$6.52M$18.75M
Current liabilities$40.67M$33.27M$27.93M$21.58M$3.47M
Long-term debt————$2.69M
Total debt————$2.69M
Total liabilities$43.58M$36.98M$31.65M$26.92M$7.27M
Shareholders' equity-$39.53M-$32.47M-$28.53M-$20.41M$10.97M
Net debt————$676,110
Shares outstanding32.96M32.96M32.96M32.96M27.17M
Cash flow statement
Operating cash flow-$549,019-$1.71M-$6.80M-$3.38M-$1.55M
Capital expenditure——$82,918$80,680$330,439
Free cash flow——-$6.88M-$3.46M-$1.89M
Investing cash flow$10,000$7,000$63,779-$80,680-$330,439
Financing cash flow$525,000$1.71M$6.74M$3.46M-$693,050
Depreciation & amortization$17,527$34,569$44,805$88,562$941,836
Stock-based compensation———$4,188$1.17M

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.